# Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

In Annex I to Regulation (EU) No 1141/2010, the entry for Famoxadone is replaced by the following:
Column A
Column B
Column C
Column D
‘Famoxadone
2012
FI
31 August 2012’

---
Source: https://www.legislation.gov.uk/eur/2019/336/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-336/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.